PVLA Palvella Therapeutics, Inc. - Common Stock
PVLA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
PVLA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
PVLA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 6 27.3%
- 매수 15 68.2%
- 보유 1 4.5%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
15 명의 애널리스트 · 2026-08-17실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-1.52 | $-1.18 | -0.34% |
| 2026년 3월 31일 | $-1.20 | $-0.95 | -0.25% |
| 2025년 12월 31일 | $-1.07 | $-0.93 | -0.14% |
| 2025년 9월 30일 | $-1.03 | $-0.86 | -0.17% |
| 2025년 6월 30일 | $-0.86 | $-0.76 | -0.10% |
| 2025년 3월 31일 | $-0.74 | $-1.24 | 0.50% |
| 2024년 12월 31일 | $-2.72 | $-0.66 | -2.1% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| GENB | — | — | — | — | — | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| R&D Expense | $23M | $8M | $9M | $53M | $67M | $47M | $55M | $41M | $22M | $20M | $8M | $6M | |
| SG&A Expense | $16M | $6M | $3M | $16M | $17M | $17M | $18M | $18M | $18M | $9M | $8M | $7M | |
| Operating Expenses | $39M | $14M | $12M | $69M | $83M | $63M | $73M | $60M | $40M | $29M | $17M | $13M | |
| Operating Income | $-39M | $-14M | $-12M | $-43M | $-52M | $-34M | $-27M | $-31M | $-15M | $-23M | $-14M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Other Non-op | $727.0K | $-131.0K | $712.0K | $1M | $2M | $-4M | $-26.0K | $2M | $-2M | $120.0K | $10.9K | $3.0K | |
| Pretax Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-17M | $-23M | $-14M | $-10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $164.0K | $0 | $-312.0K | $1M | $162.0K | $203.9K | $-18 | |
| Net Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| EPS (Basic) | $-3.71 | $-7.83 | $2.19 | $-0.45 | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.71 | $-7.83 | $2.17 | · | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| Shares (Basic) | 11,251,250 | 2,225,934 | 1,770,167 | 74,172,000 | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 11,251,250 | 2,225,934 | 1,793,980 | · | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-14M | · | $-41M | · | $-34M | $-27M | $-31M | $-15M | · | · | · |
대차대조표 24
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $84M | $7M | $39M | $118M | $70M | $62M | $75M | $38M | $29M | $29M | $18M | |
| Short-term Investments | $0 | · | $9M | $21M | $0 | $0 | $42M | $53M | $35M | $0 | · | · | |
| Receivables | $0 | $358.0K | $0 | $6M | $3M | $2M | $7M | $3M | $16M | $57.0K | $0 | $0 | |
| Prepaid Expense | $1M | $2M | $198.0K | $3M | $7M | $4M | $4M | $5M | $2M | $3M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $59M | $88M | $8M | $73M | $128M | $76M | $115M | $135M | $90M | $33M | $32M | $20M | |
| PP&E (Net) | · | · | $0 | $17M | $19M | $22M | $20M | $5M | $4M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | $27M | $27M | $28M | $23M | $8M | $7M | $5M | $4M | $4M | |
| Accum. Depreciation | · | · | · | $10M | $8M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $0 | $1M | $3M | $3M | $3M | $910.0K | $130.0K | $126.0K | $126.8K | · | |
| Total Assets | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Accounts Payable | $5M | $5M | $936.0K | $4M | $9M | $2M | $6M | $3M | $2M | $2M | $1M | · | |
| Accrued Liabilities | · | · | · | · | · | $8M | $10M | $9M | $6M | $4M | $2M | $986.6K | |
| Current Liabilities | $11M | $12M | $2M | $37M | $51M | $22M | $27M | $48M | $46M | $8M | $3M | $4M | |
| Capital Leases | $431.0K | $0 | $0 | $12M | $14M | $16M | $15M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | $6.0K | $0 | $27.0K | $37.0K | $47.0K | $23.9K | $334.0K | |
| Total Liabilities | $32M | $26M | $11M | $68M | $103M | $74M | $90M | $101M | $92M | $10M | $3M | $4M | |
| Common Stock | $12.0K | $11.0K | $0 | $74.0K | $72.0K | $56.0K | $55.0K | $54.0K | $45.0K | $43.0K | $39.8K | $29.3K | |
| Paid-in Capital | $163M | $156M | $2M | $319M | $307M | · | · | · | · | · | $112M | $85M | |
| Retained Earnings | $-135M | $-94M | $-76M | $-290M | $-257M | $-211M | $-174M | $-147M | $-120M | $-103M | $-80M | $-66M | |
| AOCI | $83.0K | $3.0K | $0 | $-254.0K | $829.0K | $-295.0K | $-2M | $-3M | $-5M | $-2M | $-1M | $-843.1K | |
| Stockholders' Equity | $28M | $63M | $-74M | $-94M | $51M | $31M | $51M | $40M | $12M | $25M | $31M | $18M | |
| Liabilities + Equity | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Shares Outstanding | 12,380,933 | 11,012,105 | 1,770,167 | 74,519,103 | 72,222,661 | 56,003,000 | 55,212,437 | 54,151,219 | 45,017,062 | 43,058,827 | 39,833,023 | 29,279,522 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2M | $3M | $2M | · | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $830.0K | $603.0K | $4M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | $571.4K | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $0 | $-164.0K | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-34M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-11M | $-14M | $-60M | $-8M | $-46M | $-52M | $-1M | $50M | $-14M | $-13M | $-5M | |
| CapEx | · | · | $171.0K | $1M | $949.0K | $3M | $2M | $2M | $2M | $560.0K | $620.7K | $267.4K | |
| Investing Cash Flow | · | · | $12M | $-21M | $-949.0K | $39M | $10M | $-9M | $-46M | · | · | · | |
| Stock Issued | · | · | $20M | $7M | $38M | $10M | · | · | · | · | $26M | $12M | |
| Net Stock Activity | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-660.0K | $87M | $5M | $7M | $59M | $10M | $32M | $49M | $4M | · | · | · | |
| Net Change in Cash | $-26M | $76M | $-9M | $-79M | $47M | $8M | $-13M | $37M | $9M | $6.0K | $11M | $15M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $51.7K | |
| Free Cash Flow | · | · | · | $-61M | · | $-49M | $-55M | $-3M | $48M | · | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1490.4% | · | · | -167.8% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| Net Margin | -1610.6% | · | · | -128.5% | · | -127.0% | -55.0% | -91.9% | -69.8% | · | · | · | |
| Pretax Margin | -1610.6% | · | · | -128.5% | · | -126.4% | -55.0% | -93.0% | -65.5% | · | · | · | |
| EBITDA Margin | -1490.4% | · | · | -157.1% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| ROA | -56.5% | -36.4% | · | -26.7% | · | -30.3% | -17.9% | -21.8% | -25.4% | · | · | · | |
| ROE | -110.1% | 140.6% | · | -92.1% | · | -99.7% | -70.8% | -59.3% | -96.0% | · | · | · | |
| ROIC | -137.9% | -22.5% | · | -155.7% | · | -109.8% | -52.9% | -76.3% | -135.1% | · | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 7.3 | · | 2.0 | · | 3.4 | 4.3 | 2.8 | 2.0 | · | · | · | |
| Quick Ratio | 5.1 | 7.0 | · | 1.8 | · | 3.3 | 4.1 | 2.7 | 1.9 | · | · | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.2 | · | 0.2 | 0.3 | 0.2 | 0.4 | · | · | · | |
| Receivables Turnover | 14.5 | · | · | 5.7 | · | 6.9 | 9.8 | 3.2 | 3.2 | · | · | · |
성장률 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 65.3% | -17.6% | 7.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 13.4% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| Net Income TTM | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| Market Cap | $1.30B | $132M | · | $6.20B | · | $11.20B | $15.99B | $11.52B | $27.19B | · | · | · | |
| P/E | -28.2 | -1.5 | 6.7 | -118.9 | -425.9 | -294.1 | · | · | · | · | · | · | |
| P/S | 66.2 | 6.8 | · | 239.4 | · | 382.0 | 345.5 | 396.0 | 1075.8 | · | · | · | |
| P/B | 46.3 | 2.1 | · | 222.0 | · | 361.0 | 311.4 | 288.6 | 2359.9 | · | · | · | |
| P / Tangible Book | 46.3 | 2.1 | · | · | 430.3 | 361.0 | · | · | · | · | · | · | |
| P / Cash Flow | -51.8 | -12.2 | · | -103.5 | · | -244.0 | -304.8 | -10809.9 | 546.5 | · | · | · | |
| P / FCF | · | · | · | -101.7 | · | -230.4 | -291.1 | -4169.1 | 568.8 | · | · | · | |
| Earnings Yield | -3.5% | -65.2% | 14.9% | -0.84% | -0.23% | -0.34% | · | · | · | · | · | · |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | $53.0K | · | $20M | $20M | $2M | $6M | $5M | |
| R&D Expense | $12M | $9M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $984.0K | $-29M | $10M | $14M | $13M | $13M | $14M | |
| SG&A Expense | $9M | $6M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | $775.0K | $-11M | $7M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $21M | $15M | $11M | $10M | $9M | $8M | $4M | $5M | $3M | $2M | $-55M | $31M | $18M | $17M | $17M | $18M | |
| Operating Income | $-21M | $-15M | $-11M | $-10M | $-9M | $-8M | $-4M | $-5M | $-3M | $-2M | $13M | $-12M | $2M | $-16M | $-12M | $-12M | |
| Other Non-op | $-8.0K | $-32.0K | $-92.0K | $34.0K | $561.0K | $224.0K | $-175.0K | $-20.0K | $64.0K | $0 | $424.0K | $506.0K | $-161.0K | $-57.0K | $-325.0K | $723.0K | |
| Pretax Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | $39M | $-11M | $4M | $-13M | $-8M | $-10M | |
| EPS (Basic) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $21.41 | $-8.70 | $3.63 | $-14.15 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $20.50 | $-8.70 | $3.62 | · | · | · | |
| Shares (Basic) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | -1,491,833 | 1,236,000 | 1,095,000 | 931,000 | -148,061,000 | 74,397,000 | |
| Shares (Diluted) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | 704,980 | 1,236,000 | 1,098,000 | · | · | · | |
| EBITDA | $-21M | $-15M | · | $-10M | $-9M | $-8M | · | $-3M | $-4M | $-5M | · | $-12M | $2M | $-15M | · | $-12M |
대차대조표 22
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $188M | $206M | $58M | $64M | $70M | $76M | $84M | $19M | $20M | $19M | $7M | $33M | $45M | $40M | $39M | $48M | |
| Short-term Investments | $63M | $55M | · | · | · | · | · | $0 | $0 | $0 | · | $12M | $10M | $9M | $21M | $21M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $358.0K | $373.0K | $1M | $2M | $0 | $1M | $952.0K | $1M | $6M | $829.0K | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $280.0K | $649.0K | $3M | $198.0K | $9M | $11M | $11M | $3M | $8M | |
| Current Assets | $253M | $263M | $59M | $67M | $74M | $79M | $88M | · | · | · | $8M | $59M | $66M | $61M | $73M | $79M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $0 | $16M | $17M | $17M | $16M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $24M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | $11M | $10M | $10M | $8M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $287.0K | $1M | $1M | $1M | $1M | |
| Total Assets | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Accounts Payable | $7M | $5M | $5M | $3M | $5M | $4M | $5M | $801.0K | $969.0K | $2M | $936.0K | $3M | $8M | $6M | $4M | $4M | |
| Current Liabilities | $12M | $9M | $11M | $10M | $10M | $9M | $12M | $4M | $6M | $8M | $2M | $29M | $34M | $43M | $37M | $34M | |
| Capital Leases | $318.0K | $375.0K | $431.0K | · | · | · | $0 | · | · | · | · | $0 | $12M | $12M | $12M | $11M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Total Liabilities | $37M | $31M | $32M | $28M | $26M | $24M | $26M | · | · | · | $11M | $29M | $47M | $67M | $68M | $63M | |
| Common Stock | $14.0K | $14.0K | $12.0K | $11.0K | $11.0K | $11.0K | $11.0K | $1.0K | $1.0K | $1.0K | $0 | $99.0K | $99.0K | $74.0K | $74.0K | $74.0K | |
| Paid-in Capital | $390M | $383M | $163M | $161M | $159M | $157M | $156M | $343M | $343M | $342M | $2M | $341M | $340M | $319M | $319M | $317M | |
| Retained Earnings | $-173M | $-151M | $-135M | $-123M | $-111M | $-102M | $-94M | $-326M | $-323M | $-320M | $-76M | $-310M | $-300M | $-304M | $-290M | $-282M | |
| AOCI | $89.0K | $95.0K | $83.0K | $104.0K | $-111.0K | $-3.0K | $3.0K | $-316.0K | $-436.0K | $-346.0K | $0 | $-339.0K | $-137.0K | $-426.0K | $-254.0K | $524.0K | |
| Stockholders' Equity | $217M | $232M | $28M | $39M | $48M | $56M | $63M | $16M | $19M | $22M | $-74M | $31M | $40M | $15M | $28M | $36M | |
| Liabilities + Equity | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Shares Outstanding | 14,395,705 | 14,313,659 | 12,380,933 | 11,088,329 | 11,059,665 | 11,021,389 | 11,012,105 | 1,320,240 | 1,320,240 | 1,236,688 | 1,770,167 | · | 98,851,927 | 74,519,103 | 74,519,103 | 74,406,253 |
현금 흐름 11
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $-30.0K | · | $739.0K | $758.0K | $605.0K | $575.0K | $767.0K | |
| Stock-based Comp | $5M | $3M | $2M | $2M | $1M | $1M | $268.0K | $-331.0K | $-109.0K | $146.0K | $-2M | $966.0K | $1M | $884.0K | $949.0K | $974.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-13M | $-11M | $-5M | $-8M | $-5M | $-7M | $-5M | $3M | $4M | $-1M | $20M | $-10M | $-13M | $-11M | $-13M | $-9M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $69.0K | $67.0K | $48.0K | $-11.0K | $34.0K | |
| Investing Cash Flow | $-7M | $-55M | · | · | $0 | $0 | · | $142.0K | $2M | $9M | · | $-2M | $-1M | $12M | $1M | $5M | |
| Stock Issued | $0 | $230M | · | · | $0 | $0 | · | $0 | · | · | · | $0 | $20M | $0 | $0 | $282.0K | |
| Net Stock Activity | · | $230M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $215M | $-49.0K | $242.0K | $349.0K | $-1M | $75M | $12M | $10M | $0 | $-15M | $0 | $20M | $0 | $93.0K | $282.0K | |
| Net Change in Cash | $-19M | $148M | $-6M | $-7M | $-5M | $-8M | $69M | $5M | $5M | $-1M | $-3M | $-12M | $5M | $1M | $-10M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $-11M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10005.7% | · | -60.5% | 10.3% | -801.2% | · | -226.6% | |
| Net Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | -9230.2% | · | -55.1% | 19.8% | -680.9% | · | -181.3% | |
| Pretax Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10062.3% | · | -60.5% | 10.3% | -769.9% | · | -226.6% | |
| ROA | -13.4% | -9.2% | · | -25.9% | -19.2% | -15.0% | · | -7.2% | -6.4% | -8.8% | · | -13.6% | 3.9% | -12.0% | · | -7.4% | |
| ROE | -16.5% | -10.9% | · | -41.3% | -28.5% | -21.1% | · | -12.3% | -12.1% | -26.2% | · | -32.5% | 9.4% | -38.3% | · | -21.7% | |
| ROIC | -9.9% | -6.4% | · | -26.3% | -19.4% | -14.2% | · | · | · | · | · | · | · | · | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.2 | 28.9 | · | 6.5 | 7.7 | 8.8 | · | · | · | · | · | 2.0 | 1.9 | 1.4 | · | 2.3 | |
| Quick Ratio | 21.0 | 28.7 | · | 6.2 | 7.3 | 8.4 | · | 4.6 | 3.3 | 2.8 | · | 1.6 | 1.6 | 1.2 | · | 2.1 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.2 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 3.4 | 0.9 | 0.8 | · | 0.0 | 0.0 | 0.0 | · | 20.8 | 18.1 | 1.4 | · | 1.4 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | · | $20M | $20M | $20M | · | $20M | $40M | $42M | · | $47M | $31M | $22M | · | $24M | |
| Net Income TTM | $-58M | $-45M | · | $-36M | $-29M | $-22M | · | $-24M | $-13M | $-22M | · | $-30M | $-29M | $-38M | · | $-42M | |
| Market Cap | $2.20B | $1.78B | · | $695M | $249M | $308M | · | $22M | $13M | $18M | · | · | $1.31B | $5.82B | · | $6.85B | |
| P/E | -33.1 | -32.5 | · | -9.5 | -2.8 | -3.2 | · | -1.0 | -1.1 | · | · | · | · | -111.5 | · | -131.4 | |
| P/S | 112.4 | 91.2 | · | 35.5 | 12.7 | 15.8 | · | 1.1 | 0.3 | 0.4 | · | · | 42.3 | 264.6 | · | 283.9 | |
| P/B | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Tangible Book | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Cash Flow | · | -164.2 | · | · | · | -45.6 | · | · | · | -2.6 | · | · | · | -529.1 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -2.6 | · | · | · | -526.8 | · | · | |
| Earnings Yield | -3.0% | -3.1% | · | -10.5% | -35.5% | -31.1% | · | -100.4% | -92.7% | · | · | · | · | -0.90% | · | -0.76% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | — | — | $43M | $26M | $31M |
| 영업이익률 % | -1490.4% | — | — | -167.8% | — |
| 순이익 | $-42M | $-17M | $19M | $-33M | $-46M |
| 희석 EPS | $-3.71 | $-7.83 | $2.17 | — | $-0.71 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 5.2 | 7.3 | — | 2.0 | — |
| 당좌 비율 | 5.1 | 7.0 | — | 1.8 | — |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | — | — | — | $-61M | — |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 212개의 제출자 · $1.9B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 44 (-26 이전 분기 대비) | 19 (-3 이전 분기 대비) | 86 (+21 이전 분기 대비) | 46 (+13 이전 분기 대비) | +709K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $173,512,745 | 1,135,406 | 9.19% | 주식 |
| Frazier Life Sciences Management, L.P. | $134,848,368 | 882,400 | 7.14% | 주식 |
| JENNISON ASSOCIATES LLC | $124,781,044 | 816,523 | 6.61% | 주식 |
| First Light Asset Management, LLC | $117,961,911 | 771,901 | 6.25% | 주식 |
| BVF INC/IL | $102,815,615 | 672,789 | 5.45% | 주식 |
| STATE STREET CORP | $99,817,745 | 653,172 | 5.29% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $78,517,999 | 513,794 | 4.16% | 주식 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $73,175,272 | 478,833 | 3.88% | 주식 |
| FEDERATED HERMES, INC. | $66,173,352 | 433,015 | 3.51% | 주식 |
| VANGUARD GROUP INC | $51,885,966 | 495,710 | 2.75% | 주식 |
| Woodline Partners LP | $48,522,948 | 317,517 | 2.57% | 주식 |
| ORBIMED ADVISORS LLC | $44,678,455 | 292,360 | 2.37% | 주식 |
| Siren, L.L.C. | $39,348,858 | 257,485 | 2.08% | 주식 |
| PRIMECAP MANAGEMENT CO/CA/ | $39,149,734 | 256,182 | 2.07% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $36,385,548 | 238,031 | 1.93% | 주식 |
| EVENTIDE ASSET MANAGEMENT, LLC | $35,375,385 | 231,484 | 1.87% | 주식 |
| EMERALD ADVISERS, LLC | $35,070,051 | 229,486 | 1.86% | 주식 |
| FMR LLC | $32,814,733 | 214,728 | 1.74% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $31,557,391 | 253,168 | 1.67% | 주식 |
| MPM BIOIMPACT LLC | $31,179,406 | 204,027 | 1.65% | 주식 |
| GOLDMAN SACHS GROUP INC | $28,993,469 | 189,723 | 1.54% | 주식 |
| First Turn Management, LLC | $23,908,689 | 156,450 | 1.27% | 주식 |
| Bellevue Group AG | $23,687,100 | 155,000 | 1.26% | 주식 |
| Caption Management, LLC | $21,394,800 | 140,000 | 1.13% | 풋 옵션 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $19,843,219 | 129,847 | 1.05% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19,707,973 | 128,962 | 1.04% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18,430,092 | 120,600 | 0.98% | 콜 옵션 |
| Aberdeen Group plc | $18,374,771 | 120,238 | 0.97% | 주식 |
| NEXTBio Capital Management LP | $13,739,893 | 89,909 | 0.73% | 주식 |
| Clio Asset Management LLC | $13,194,937 | 86,343 | 0.70% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11,706,012 | 76,600 | 0.62% | 풋 옵션 |
| VANGUARD FIDUCIARY TRUST CO | $11,307,916 | 73,995 | 0.60% | 주식 |
| Avidity Partners Management LP | $10,697,400 | 70,000 | 0.57% | 주식 |
| AWM Investment Company, Inc. | $10,608,153 | 69,416 | 0.56% | 주식 |
| SEVEN GRAND MANAGERS, LLC | $9,169,200 | 60,000 | 0.49% | 주식 |
| Clearbridge Investments, LLC | $9,068,458 | 59,341 | 0.48% | 주식 |
| NEUBERGER BERMAN GROUP LLC | $8,445,444 | 55,264 | 0.45% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $8,140,721 | 53,270 | 0.43% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $7,979,038 | 52,212 | 0.42% | 주식 |
| Ensign Peak Advisors, Inc | $7,894,681 | 51,660 | 0.42% | 주식 |
| Nicholas Investment Partners, LP | $7,597,905 | 49,718 | 0.40% | 주식 |
| Balyasny Asset Management L.P. | $6,805,992 | 44,536 | 0.36% | 주식 |
| Lisanti Capital Growth, LLC | $6,567,440 | 42,975 | 0.35% | 주식 |
| WCM INVESTMENT MANAGEMENT, LLC | $6,215,278 | 40,140 | 0.33% | 주식 |
| ROYCE & ASSOCIATES LP | $6,190,585 | 40,509 | 0.33% | 주식 |
| ORBIMED ADVISORS LLC | $6,112,800 | 40,000 | 0.32% | 콜 옵션 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $6,092,169 | 39,865 | 0.32% | 주식 |
| Apis Capital Advisors, LLC | $5,959,980 | 39,000 | 0.32% | 주식 |
| Blue Owl Capital Holdings LP | $5,541,100 | 36,259 | 0.29% | 주식 |
| FIFTH THIRD BANCORP | $5,438,100 | 35,585 | 0.29% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4,979,334 | 32,583 | 0.26% | 주식 |
| FRED ALGER MANAGEMENT, LLC | $4,802,216 | 31,424 | 0.25% | 주식 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $4,786,017 | 31,318 | 0.25% | 주식 |
| CITADEL ADVISORS LLC | $4,645,728 | 30,400 | 0.25% | 콜 옵션 |
| Caption Management, LLC | $4,584,600 | 30,000 | 0.24% | 콜 옵션 |
| BANK OF AMERICA CORP /DE/ | $4,577,265 | 29,952 | 0.24% | 주식 |
| JANE STREET GROUP, LLC | $4,095,576 | 26,800 | 0.22% | 콜 옵션 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3,820,500 | 25,000 | 0.20% | 주식 |
| NOMURA HOLDINGS INC | $3,662,026 | 23,963 | 0.19% | 주식 |
| Legato Capital Management LLC | $3,589,741 | 23,490 | 0.19% | 주식 |
| TD Asset Management Inc | $3,476,044 | 22,746 | 0.18% | 주식 |
| ACT CAPITAL MANAGEMENT, LLC | $3,438,450 | 22,500 | 0.18% | 주식 |
| Swiss National Bank | $2,964,708 | 19,400 | 0.16% | 주식 |
| Informed Momentum Co LLC | $2,880,504 | 18,849 | 0.15% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $2,762,833 | 18,079 | 0.15% | 주식 |
| F/m Investments LLC | $2,666,098 | 17,446 | 0.14% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,658,610 | 17,397 | 0.14% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2,375,587 | 15,545 | 0.13% | 주식 |
| CITIGROUP INC | $2,270,905 | 14,860 | 0.12% | 주식 |
| ALPS ADVISORS INC | $2,193,884 | 14,356 | 0.12% | 주식 |
| Capricorn Fund Managers Ltd | $2,152,928 | 14,088 | 0.11% | 주식 |
| RHUMBLINE ADVISERS | $2,067,339 | 13,528 | 0.11% | 주식 |
| Trexquant Investment LP | $2,062,306 | 13,495 | 0.11% | 주식 |
| CITADEL ADVISORS LLC | $2,032,506 | 13,300 | 0.11% | 풋 옵션 |
| BlackRock, Inc. | $1,945,093 | 12,728 | 0.10% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $1,878,769 | 12,294 | 0.10% | 주식 |
| OAK RIDGE INVESTMENTS LLC | $1,839,647 | 12,038 | 0.10% | 주식 |
| Cresset Asset Management, LLC | $1,777,144 | 11,629 | 0.09% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $1,762,167 | 11,531 | 0.09% | 주식 |
| Rafferty Asset Management, LLC | $1,736,188 | 11,361 | 0.09% | 주식 |
| Bank of New York Mellon Corp | $1,633,340 | 10,688 | 0.09% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $1,593,913 | 10,430 | 0.08% | 주식 |
| Mariner, LLC | $1,583,364 | 10,361 | 0.08% | 주식 |
| Knights of Columbus Asset Advisors LLC | $1,532,937 | 10,031 | 0.08% | 주식 |
| XTX Topco Ltd | $1,354,138 | 8,861 | 0.07% | 주식 |
| MARTINGALE ASSET MANAGEMENT L P | $1,284,605 | 8,406 | 0.07% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $1,208,195 | 7,906 | 0.06% | 주식 |
| MetLife Investment Management, LLC | $978,812 | 6,405 | 0.05% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $977,895 | 6,399 | 0.05% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $976,825 | 6,392 | 0.05% | 주식 |
| Vanguard Global Advisers, LLC | $948,859 | 6,209 | 0.05% | 주식 |
| ASPIRIANT, LLC | $894,303 | 5,852 | 0.05% | 주식 |
| PROFUND ADVISORS LLC | $879,173 | 5,753 | 0.05% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $873,519 | 5,716 | 0.05% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $859,462 | 6,895 | 0.05% | 주식 |
| Penn Capital Management Company, LLC | $841,427 | 5,506 | 0.04% | 주식 |
| ExodusPoint Capital Management, LP | $839,593 | 5,494 | 0.04% | 주식 |
| Squarepoint Ops LLC | $790,996 | 5,176 | 0.04% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $787,176 | 5,151 | 0.04% | 주식 |
| CAPTRUST FINANCIAL ADVISORS | $722,991 | 4,731 | 0.04% | 주식 |
회사 내부자 23 명의 내부자 · 10 임원 · 15 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Kaupinen Wes | President and CEO | 2026년 2월 5일 A | — | 0 | 0 | $0 |
| Stephen S. Yoder | Chief Executive Officer | 2017년 2월 23일 A | 6,000 | 0 | 0 | $0 |
| Matthew E Korenberg | CFO, Treasurer | 2026년 6월 12일 M | 1,000 | 0 | 0 | $0 |
| Allan Reine | SVP and Chief Financial Officer | 2017년 8월 17일 P | 65,000 | 0 | 0 | $0 |
| Darlene M Deptula-Hicks | SVP, Chief Financial Officer | 2016년 6월 13일 P | 5,000 | 0 | 0 | $0 |
| Kathleen Goin | Chief Operating Officer | 2026년 7월 15일 M | 0 | 0 | 25 | $-4,196,766 |
| Ashley Hartmann Kline | Chief Commercial Officer | 2026년 2월 5일 A | — | 0 | 0 | $0 |
| Jeffrey S Martini | Chief Scientific Officer | 2026년 2월 5일 A | — | 0 | 0 | $0 |
| Louis Matis | SVP, Chief Development Officer | 2017년 2월 23일 A | 10,000 | 0 | 0 | $0 |
| Claude Knopf | Chief Business Officer | 2016년 11월 28일 A | — | 0 | 0 | $0 |
| Matthew Pauls | 이사 | 2026년 6월 29일 A | — | 0 | 0 | $0 |
| Tadd S. Wessel | 이사 | 2026년 6월 10일 A | — | 0 | 0 | $0 |
| John Doux | 이사 | 2026년 6월 10일 A | — | 0 | 0 | $0 |
| Todd C Davis | 이사 | 2026년 6월 10일 A | — | 0 | 0 | $0 |
| George M Jenkins | 이사 | 2026년 6월 10일 A | 187,616 | 2 | 0 | $549,974 |
| Christopher P Kiritsy | 이사 | 2026년 6월 10일 A | 5,000 | 0 | 0 | $0 |
| Elaine J Heron | 이사 | 2026년 6월 10일 A | 47,812 | 1 | 0 | $300,000 |
| James A Geraghty | 이사 | 2017년 8월 17일 P | 10,000 | 0 | 0 | $0 |
| Chau Quang Khuong | 이사 | 2017년 7월 25일 A | 65,398 | 0 | 0 | $0 |
| Michael Richman | 이사 | 2017년 7월 25일 A | — | 0 | 0 | $0 |
| Jean-Pierre Bizzari | 이사 | 2017년 1월 25일 A | — | 0 | 0 | $0 |
| Steven Prelack | 이사 | 2017년 1월 25일 A | — | 0 | 0 | $0 |
| Julian Adams | 이사 | 2017년 1월 25일 A | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 3 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Kaupinen Wes, Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Christine L. Kaupinen, Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Michael Christopher | 2024년 12월 20일 | 14.60% | 최초 제출 | — | SEC |
| Biotechnology Value Fund, L.P., BVF I GP LLC, Biotechnology Value Fund II, L.P., BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP Holdings LLC, BVF Partners L.P., BVF Inc., Mark N. Lampert ×2 제출 서류 | 2023년 8월 17일 | — | 최초 제출 | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×10 제출 서류 | 2018년 9월 27일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 30 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 1.95% | 17,254 NS | 2026년 5월 31일 | N-PORT |
| SBIO · ALPS ETF Trust | 1.03% | 14,096 NS | 2026년 5월 31일 | N-PORT |
| BBC · ETFis Series Trust I | 0.96% | 2,798 NS | 2026년 4월 30일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.39% | 15,705 NS | 2026년 4월 30일 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.05% | 4,017 NS | 2026년 5월 31일 | N-PORT |
| RSSL · Global X Funds | 0.03% | 3,330 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.02% | 364 NS | 2026년 5월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 4,496 NS | 2026년 4월 30일 | N-PORT |
| UWM · ProShares Trust | 0.01% | 285 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.01% | 288 NS | 2026년 5월 31일 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 3,843 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 7 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 232 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 218 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026년 7월 30일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| ITOT · iShares Trust | — | — | 2026년 7월 22일 | 일간 |
| IWV · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWO · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWM · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| VHT · VANGUARD WORLD FUND | — | — | 2026년 7월 20일 | 일간 |
| ISCB · iShares Trust | — | — | 2026년 7월 21일 | 일간 |
| ISCG · iShares Trust | — | — | 2026년 7월 21일 | 일간 |
| ISCV · iShares Trust | — | — | 2026년 7월 20일 | 일간 |
| SMMV · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| WSML · iShares Trust | — | — | 2026년 7월 20일 | 일간 |